Clinical trial

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no…

NCT00240955 · Novartis, Industry · Completed

Key facts

NCT number NCT00240955
Title Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients
Official title Efficacy and Safety of Two Immunosuppressive Regimens Mycophenolate Sodium (EC-MPS) With Short-term Steroid Use or Free of Steroids Compared With a Regimen of EC-MPS With Standard Steroids in de Novo Kidney Recipients
Lead sponsor Novartis, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Renal Transplantation
Intervention type Drug
Interventions Enteric-coated Mycophenolate sodium (EC-MPS)
Enrollment 79
Start date Mar 1, 2004
Primary completion May 1, 2006
Completion May 1, 2006
First posted Oct 18, 2005
Last update posted Feb 23, 2017

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies